腺苷酸激酶4在恶性肿瘤中的研究进展

牛良晨; 李力

doi:10.3969/j.issn.1000-8179.2012.07.452

腺苷酸激酶4在恶性肿瘤中的研究进展

doi: 10.3969/j.issn.1000-8179.2012.07.452

牛良晨,
李力^,

广西医科大学附属肿瘤医院妇瘤科，区域性高发肿瘤早期防治研究教育部重点实验室（南宁市530021）

基金项目:

广西科学研究与技术开发计划项目 guikegong 1140003A-33

详细信息

作者简介:
牛良晨专业方向为妇科肿瘤临床诊治及卵巢癌铂类耐药的基础研究。E-mail：1923546470@qq.com

通讯作者:
李力 lili@gxmu.edu.cn

计量
- 文章访问数: 188
- HTML全文浏览量: 15
- PDF下载量: 29
- 被引次数: 0
出版历程
- 收稿日期: 2020-12-10
- 刊出日期: 2021-04-15

Research progress of adenylate kinase 4 in malignant tumors

Liangchen Niu,
Li Li^,

Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Key laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Ministry of Education), Nanning 530021, China

Funds:

the Guangxi Scientific Research and Technology Development Project guikegong 1140003A-33

More Information

Corresponding author: Li Li; E-mail: lili@gxmu.edu.cn

摘要

摘要: 腺苷酸激酶4（adenylate kinase 4，AK4）是腺苷酸激酶家族的成员之一，具有调节细胞腺嘌呤核苷三磷酸（adenosine triphosphate，ATP）浓度的生物学功能，在调节细胞能量代谢过程中起重要作用，同时也在缺氧耐受、肿瘤的发展、抗肿瘤药物耐药、调节线粒体活性等方面发挥重要作用。恶性肿瘤一直是严重威胁人类健康的疾病，许多肿瘤的死亡率居高不下。恶性肿瘤的发生、发展及治疗一直是科学研究的热点，肿瘤的治疗在不断改进，尽管在部分领域取得一定进展，但总体来说，我们对肿瘤的认识，尤其是治疗、耐药后治疗仍未突破瓶颈。AK4被用作抗癌治疗的潜在治疗靶点，而AK4与肿瘤之间的确切关系尚未得到进一步的阐明。本文拟对AK4的研究现状作一综述，以期对AK4及其在临床及疾病中的研究提供新思路。
- 腺苷酸激酶4 /
- 恶性肿瘤 /
- 信号通路 /
- 能量代谢
Abstract: Adenylate kinase 4 (AK4), a member of the adenylate kinase family, regulates the concentration of cellular ATP and plays a pivotal role in the regulation of energy metabolism in cells. It also plays a crucial role in hypoxia tolerance, tumor development, anti-tumor drug resistance, and regulation of mitochondrial activity. Malignant tumors are a serious threat to human health; the mortality rate associated with malignant tumors remains high. The occurrence, development, and treatment of malignant tumors have long been the prime focus of scientific research. Although tumor treatment is continuously improving and a steady progress is seen with regard to our understanding of tumors in general, no breakthroughs, especially the identification of therapeutic targets and strategies for the treatment of post-drug resistance, have been achieved. AK4 is a potential therapeutic target for anticancer therapy; however, the exact relationship between AK4 and tumor development has not yet been established clearly. In view of the ongoing progress and unmet challenges, this article intends to summarize the current status of research regarding AK4, aiming to provide novel ideas for clinical and disease-related studies regarding this aspect.
- adenylate kinase 4(AK4) /
- malignant tumor /
- signal pathway /
- energy metabolism

HTML全文

参考文献(40)

[1]	Liu H, Pu Y, Amina Q, et al. Prognostic and therapeutic potential of Adenylate kinase 2 in lung adenocarcinoma[J]. Sci Rep, 2019, 9(1): 17757. doi: 10.1038/s41598-019-53594-4
[2]	Ye C, Ding C, Ma R, et al. Electrostatic interactions determine entrance/release order of substrates in the catalytic cycle of adenylate kinase[J]. Proteins, 2019, 87(4): 337-347. doi: 10.1002/prot.25655
[3]	Zeiner J, Loukovaara S, Losenkova K, et al. Soluble and membranebound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage[J]. J Mol Med (Berl), 2019, 97(3): 341-354. doi: 10.1007/s00109-018-01734-0
[4]	Klepinin A, Zhang S, Klepinina L, et al. Adenylate kinase and metabolic signaling in cancer cells[J]. Front Oncol, 2020, 10: 660. doi: 10.3389/fonc.2020.00660
[5]	Panayiotou C, Solaroli N, Johansson M, et al. Evidence of an intact N-terminal translocation sequence of human mitochondrial adenylate kinase 4[J]. Int J Biochem Cell Biol, 2010, 42(1): 62-69. doi: 10.1016/j.biocel.2009.09.007
[6]	Lanning NJ, Looyenga BD, Kauffman AL, et al. A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels[J]. Cell Rep, 2014, 7(3): 907-917. doi: 10.1016/j.celrep.2014.03.065
[7]	Fujisawa K, Terai S, Takami T, et al. Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4[J]. J Exp Clin Cancer Res, 2016, 35: 48. doi: 10.1186/s13046-016-0322-2
[8]	Xu G, O'connell P, Stevens J, et al. Characterization of human adenylate kinase 3 (AK3) cDNA and mapping of the AK3 pseudogene to an intron of the NF1 gene[J]. Genomics, 1992, 13(3): 537-542. doi: 10.1016/0888-7543(92)90122-9
[9]	Panayiotou C, Solaroli N, Karlsson A. The many isoforms of human adenylate kinases[J]. J Exp Clin Cancer Res, 2014, 49: 75-83.
[10]	Noma T, Fujisawa K, Yamashiro Y, et al. Structure and expression of human mitochondrial adenylate kinase targeted to the mitochondrial matrix[J]. Biochem J, 2001, 358(Pt 1): 225-232. http://glycob.oxfordjournals.org/external-ref?access_num=10.1042/0264-6021:3580225&link_type=DOI
[11]	Noma T. Dynamics of nucleotide metabolism as a supporter of life phenomena[J]. J Med Invest, 2005, 52(3-4): 127-1236.
[12]	Yamamoto T, Kikkawa R, Yamada H, et al. Investigation of proteomic biomarkers in in vivo hepatotoxicity study of rat liver: toxicity differentiation in hepatotoxicants[J]. J ToxicoL Sci, 2006, 31(1): 49-60. doi: 10.2131/jts.31.49
[13]	Khatri I, Singh A, Korpole S, et al. Draft genome sequence of an alphaproteobacterium, caenispirillum linarum AK4(T), Isolated from a solar saltern[J]. Genome Anounce, 2013, 1(1): e00199-e00112. http://www.ncbi.nlm.nih.gov/pubmed/23409257
[14]	Liu R, Strom AL, Zhai J, et al. Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase[J]. Int J Biochem Cell Biol, 2009, 41(6): 1371-1380. doi: 10.1016/j.biocel.2008.12.002
[15]	Synnergren J, Drowley L, Plowright AT, et al. Comparative transcriptomic analysis identifies genes differentially expressed in human epicardial progenitors and hiPSC- derived cardiac progenitors[J]. Physiol Genomics, 2016, 48(11): 771-784. doi: 10.1152/physiolgenomics.00064.2016
[16]	Kong F, Binas B, Moon JH, et al. Differential expression of adenylate kinase 4 in the context of disparate stress response strategies of HEK293 and HepG2 cells[J]. Arch Biochem Biophys, 2013, 533(1-2): 11-17. doi: 10.1016/j.abb.2013.02.014
[17]	孔凡志, 计红, 郭丽, 等. 腺苷酸激酶4的表达对张氏肝细胞增殖的影响[J]. 中国生物制品学杂志, 2018, 31(1): 31-34. https://www.cnki.com.cn/Article/CJFDTOTAL-SWZP201801008.htm
[18]	Jan YH, Lai TC, Yang CJ, et al. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1alpha to drive lung adenocarcinoma metastasis[J]. J Hematol Oncol, 2019, 12(1): 12. doi: 10.1186/s13045-019-0698-5
[19]	Jan YH, Lai TC, Yang CJ, et al. A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma[J]. Sci Rep, 2019, 9(1): 12329. doi: 10.1038/s41598-019-48243-9
[20]	Yu L, Petyuk VA, Gaiteri C, et al. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia[J]. Annal Neurol, 2018, 84(1): 78-88. doi: 10.1002/ana.25266
[21]	Buchman AS, Yu L, Petyuk VA, et al. Cognition may link cortical IGFBP5 levels with motor function in older adults[J]. PloS One, 2019, 14(8): e0220968. doi: 10.1371/journal.pone.0220968
[22]	Kim N, Yu L, Dawe R, et al. Microstructural changes in the brain mediate the association of AK4, IGFBP5, HSPB2, and ITPK1 with cognitive decline[J]. Neurobiol Aging, 2019, 84: 17-25. doi: 10.1016/j.neurobiolaging.2019.07.013
[23]	Wang Y, Chen ZH, Yin C, et al. GeneChip expression profiling reveals the alterations of energy metabolism related genes in osteocytes under large gradient high magnetic fields[J]. PloS One, 2015, 10(1): e0116359. doi: 10.1371/journal.pone.0116359
[24]	Tang D, Chen Y, He H, et al. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine[J]. BMC Genomics, 2016, 17: 488. doi: 10.1186/s12864-016-2809-9
[25]	Edhager AV, Stenbroen V, Nielsen NS, et al. Proteomic investigation of cultivated fibroblasts from patients with mitochondrial short-chain acyl-CoA dehydrogenase deficiency[J]. Mol Genet Metab, 2014, 111 (3): 360-368. doi: 10.1016/j.ymgme.2014.01.007
[26]	Winterhoff BJ, Maile M, Mitra AK, et al. Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells[J]. Gynecol Oncol, 2017, 144(3): 598-606. doi: 10.1016/j.ygyno.2017.01.015
[27]	Jan YH, Tsai HY, Yang CJ, et al. Adenylate kinase- 4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3[J]. Cancer Res, 2012, 72(19): 5119-5129. doi: 10.1158/0008-5472.CAN-12-1842
[28]	Huang D, Wang Y, He Y, et al. Paraoxonase 3 is involved in the multidrug resistance of esophageal cancer[J]. Cancer Cell Int, 2018, 18 (1): 168. doi: 10.1186/s12935-018-0657-1
[29]	Xu L, Huan L, Guo T, et al. LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α[J]. Oncogene, 2020, 39(46): 7005-7018. doi: 10.1038/s41388-020-01512-8
[30]	Wu Z, Gong Q, Yu Y, et al. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis[J]. BMC Pulm Med, 2020, 20(1): 10. doi: 10.1186/s12890-019-1035-z
[31]	李辰运, 孙彤, 卓娜, 等. 胰腺导管腺癌中腺苷酸激酶4的表达及临床意义[J]. 天津医科大学学报, 2018, 24(1): 43-46. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYK201801012.htm
[32]	庞亮, 刘光明, 荆振, 等. 肌肉浸润性膀胱癌中腺苷酸激酶4的表达及临床意义[J]. 医学综述, 2018, 24(4): 812-815. doi: 10.3969/j.issn.1006-2084.2018.04.035
[33]	Xin F, Yao DW, Fan L, et al. Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion[J]. Clin Exp Med, 2019, 19(4): 525- 534. doi: 10.1007/s10238-019-00576-5
[34]	赵江涛, 张伟, 吴吉海, 等. HER2过表达型乳腺癌中AK4的表达及临床意义[J]. 医学综述, 2019, 25(12): 2479-2483. doi: 10.3969/j.issn.1006-2084.2019.12.036
[35]	Zhang J, Yin YT, Wu CH, et al. AK4 promotes the progression of her2- positive breast cancer by facilitating cell proliferation and invasion [J]. Dis Markers, 2019, 2019: 8186091. http://www.ncbi.nlm.nih.gov/pubmed/31827645
[36]	Liu X, Gonzalez G, Dai X, et al. Adenylate kinase 4 modulates the resistance of breast cancer cells to tamoxifen through an m(6)A-based epitranscriptomic mechanism[J]. Mol Ther, 2020, 28(12): 2593-2604. doi: 10.1016/j.ymthe.2020.09.007
[37]	Wang ZH, Zhang YZ, Wang YS, et al. Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer[J]. Cancer Cell Int, 2019, 19: 296. doi: 10.1186/s12935-019-1001-0
[38]	Zang C, Zhao F, Hua L, et al. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene[J]. Cancer Cell International, 2018, 18: 186. doi: 10.1186/s12935-018-0689-6
[39]	Lei W, Yan C, Ya J, et al. MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4[J]. BMC Cancer, 2018, 18(1): 631. doi: 10.1186/s12885-018-4460-0
[40]	Chen Y, Bao C, Zhang X, et al. Knockdown of LINC00662 represses AK4 and attenuates radioresistance of oral squamous cell carcinoma[J]. Cancer Cell Internat, 2020, 20: 244. doi: 10.1186/s12935-020-01286-9